Log in

NASDAQ:OMTH - Omthera Pharmaceuticals Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Omthera Pharmaceuticals, Inc is a specialty pharmaceutical company. The Company is focused on the development and commercialization of new therapies for abnormalities in blood lipids, referred to as dyslipidemia, and the treatment of cardiovascular disease. Epanova, its product candidate, is a late-stage, omega-three free fatty acid composition that reduces triglycerides, improves other key lipid parameters. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:OMTH
CUSIPN/A
CIKN/A
Phone+1-908-7414323

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive OMTH News and Ratings via Email

Sign-up to receive the latest news and ratings for OMTH and its competitors with MarketBeat's FREE daily newsletter.


Omthera Pharmaceuticals (NASDAQ:OMTH) Frequently Asked Questions

What is Omthera Pharmaceuticals' stock symbol?

Omthera Pharmaceuticals trades on the NASDAQ under the ticker symbol "OMTH."

Has Omthera Pharmaceuticals been receiving favorable news coverage?

Headlines about OMTH stock have been trending negative recently, InfoTrie Sentiment reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Omthera Pharmaceuticals earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave news articles about the specialty pharmaceutical company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Omthera Pharmaceuticals.

What other stocks do shareholders of Omthera Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Omthera Pharmaceuticals investors own include Scorpio Tankers (STNG), Corcept Therapeutics (CORT), Ceragon Networks (CRNT), Cypress Semiconductor (CY), SmileDirectClub (SDC), Sunesis Pharmaceuticals (SNSS), Sarepta Therapeutics (SRPT), Xencor (XNCR), ExOne (XONE) and Aurora Cannabis (ACB).

What is Omthera Pharmaceuticals' official website?

The official website for Omthera Pharmaceuticals is http://www.omthera.com/.

How can I contact Omthera Pharmaceuticals?

Omthera Pharmaceuticals' mailing address is 707 State Rd, PRINCETON, NJ 08540-1438, United States. The specialty pharmaceutical company can be reached via phone at +1-908-7414323.


MarketBeat Community Rating for Omthera Pharmaceuticals (NASDAQ OMTH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  75 (Vote Outperform)
Underperform Votes:  84 (Vote Underperform)
Total Votes:  159
MarketBeat's community ratings are surveys of what our community members think about Omthera Pharmaceuticals and other stocks. Vote "Outperform" if you believe OMTH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OMTH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/27/2020 by MarketBeat.com Staff

Featured Article: What is the Current Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel